Skip to main content
Mark Pollack, MD, Psychiatry, Chicago, IL

MarkHarrisPollackMD

Psychiatry Chicago, IL

Psychopharmacology

Senior Vice President for Global Medical Affairs, Sage Therapeutics

Dr. Pollack is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Pollack's full profile

Already have an account?

  • Office

    Rush University Medical Center Dept of Psychiatry
    2150 W. Harrison St.
    Chicago, IL 60612
    Phone+1 312-942-5372
    Fax+1 312-942-6216
  • Is this information wrong?

Summary

  • Dr. Mark Pollack is The Grainger Professor and Chairman of the Department of Psychiatry at Rush University Medical Center, and Director of the Road Home Program for Veterans and Their Families at Rush. He completed residency and fellowship training in psychiatry at Massachusetts General Hospital where he served as Director of the Center for Anxiety and Traumatic Stress Disorders and Professor of Psychiatry at Harvard Medical School until 2011.
    His areas of clinical and research interest include the acute and long-term course, pathophysiology and treatment of patients with anxiety disorders and associated comorbidities, development of novel pharmacologic agents for mood and anxiety disorders, uses of combined cognitive-behavioral and pharmacologic therapies for treatment refractory patients and presentation and treatment of anxiety in the medical setting.
    Dr Pollack has received federal funding from the National Institute of Mental Health (NIMH) and National Institute of Drug Abuse (NIDA) and has published over 500 articles, abstracts, reviews, chapters and books. He lectures widely in national and international forum and serves on numerous editorial and advisory boards. He is Past President and Chairman of the Scientific Advisory Board of the Anxiety and Depression Association of America and maintains an active consultative and clinical practice.

Education & Training

  • Harvard University
    Harvard UniversityM.A., with Honors, 2007
  • Massachusetts General Hospital/McLean Hospital
    Massachusetts General Hospital/McLean HospitalResidency, Psychiatry, 1982 - 1986
  • Rutgers New Jersey Medical School
    Rutgers New Jersey Medical SchoolClass of 1982
  • University of Virginia
    University of VirginiaB.A., 1978

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1987 - 2024
  • CA State Medical License
    CA State Medical License 1988 - 2024
  • IL State Medical License
    IL State Medical License 2011 - 2023
  • MA State Medical License
    MA State Medical License 1984 - 2013
  • American Board of Psychiatry and Neurology Psychiatry

Awards, Honors, & Recognition

  • Clinical Fellow ADAA, 2016
  • Research Mentoring Program Mentor of the Year Rush University, 2015
  • Excellence in Research Award Rush University Medical Center, 2015
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Examining the relationship between parent and child psychopathology in treatment-seeking veterans  
    Zalta AK, Bui E, Karnik NS, Held P, Laifer LM, Sager JC, Zou D, Rauch PK, Simon NM, Pollack MH, Ohye B, Child Psychiatry & Human Development, 1/1/2018
  • Does D-cycloserine facilitate the effects of homework compliance on social anxiety symptom reduction?  
    Roque A, Rosenfield D, Smits JAJ, Simon N, Otto MW, Marques L, Pollack MH, Hofmann SG, Meuret AE, Journal of Anxiety Disorders, 1/1/2018
  • Characteristics of veterans and military service members who endorse causing harm, injury, or death to others in the military  
    Held P, Boley RA, Karnik NS, Pollack MH, Zalta AK, Psychological Trauma: Theory, Research, Practice, and Policy, 1/1/2018
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • The management of refractory anxiety disorders, OCD, and PTSD: An update.
    VanAmeringen M, Nemeroff CB, Pollack MH, Blair Simpson H, Perna G, Annual Meeting of the American Psychiatric Association, New York, NY, 1/1/2018
  • Evaluating changes in sleep during a 3-week Intensive Outpatient Program for Veterans with PTSD.
    Wagner L, Zalta AK, Valdespino-Hayden Z, Burgess HJ, Boley RA, Held P, Pollack MH, ABCT�s 52nd Annual Confernce, Washington, DC, 1/1/2018
  • Morally injurious events and veterans� social functioning: The role of anger as a mediator.
    Bravo K, Coleman J, Klassen B, Zalta A, Pollack M, Held P, International Society for Traumatic Stress Studies 34th Annual Meeting, Washington, DC, 1/1/2018
  • Join now to see all

Lectures

  • Novel approaches to the treatment of refractory anxiety 
    University of Texas Medical School, Galveston, TX - 1/1/2018
  • Treatment of refractory social anxiety disorder 
    New York, NY, 2018; Washington, DC, 2018 - 1/1/2018
  • GAD and panic disorders 
    Las Vegas, NV - 1/1/2017
  • Join now to see all

Other

  • Coping with Anxiety. 
    Pollack MH, Health Radio Network
    1/1/2006
  • Acute Stress Disorders in the Aftermath of Hurricane Katrina 
    Pollack MH, Greater Boston PBS
    1/1/2005
  • Novel Approaches for Improving Outcomes in the Treatment of Anxiety. 
    Pollack MH, Psychlink Satellite Broadcast
    1/1/2005
  • Join now to see all

Press Mentions

  • Americans’ Anxiety Impacted by the Ongoing Pandemic, yet 1 in 5 Say They Won’t Seek Treatment According to the Genesight Mental Health Monitor Nationwide Survey
    Americans’ Anxiety Impacted by the Ongoing Pandemic, yet 1 in 5 Say They Won’t Seek Treatment According to the Genesight Mental Health Monitor Nationwide SurveyOctober 11th, 2021
  • How to Convince Your Parents to Go to Therapy
    How to Convince Your Parents to Go to TherapyDecember 11th, 2020
  • Nearly Two-Thirds of Older Adults Say They Won't Treat Their Depression
    Nearly Two-Thirds of Older Adults Say They Won't Treat Their DepressionNovember 16th, 2020
  • Join now to see all

Grant Support

  • 3/3-Exposure D-Cycloserine Enhancement And Genetic Modulators In Panic DisorderNational Institute Of Mental Health2011–2012
  • Eszopiclone For The Treatment Of PTSDNational Institute Of Mental Health2011
  • 3/3-Exposure D-Cycloserine Enhancement And Genetic Modulators In Panic DisorderNational Institute Of Mental Health2008–2011
  • D-Cycloserine Enhancement Of Exposure In Social PhobiaNational Institute Of Mental Health2007–2010
  • Improving Outcomes In Pharmacotherapy Of Social PhobiaNational Institute Of Mental Health2005–2009
  • Impact Of Trauma Of Terroist Attack On Bipolar PatientsNational Institute Of Mental Health2002–2003
  • MR Spectroscopic Imaging During Methadone MaintenanceNational Institute On Drug Abuse1998–2002
  • CBT For Illicit Drug Use In Methadone Treated PatientsNational Institute On Drug Abuse1995–1997
  • Faculty Scholar Award In Depression And Anxiety (PsychiaCenter For Mental Health Services1992
  • Faculty Scholar Award In Depression And Anxiety (PsychiaNational Institute Of Mental Health1991–1992